Safety and Efficacy of KSVCBD Injection in Multiple Myeloma Expressing CD19 and/or BCMA
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Study of Alternative and Approved Dosing Regimens of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Relapsed/Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Long Non-coding RNA (lncRNA) ZFAS1-Mediated Mechanism of Roasted Nux Vomica in Intervening Bortezomib-Induced Peripheral Neuropathy
- Status
- COMPLETED
- Phase
- NA
A Study of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Multiple Myeloma and Moderate Hepatic Impairment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Non-interventional Study of Melphalan Flufenamide (Melflufen) (Pepaxti®) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma (R/RMM)
- Status
- RECRUITING
- Phase
- N/A
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- N/A
A Phase I Study of SHR-3836 in Patients With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction
- Status
- RECRUITING
- Phase
- PHASE2
Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing
- Status
- RECRUITING
- Phase
- PHASE2
BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2